Medico Intercontinental Limited (BOM:539938)
India · Delayed Price · Currency is INR 25.50
+0.65 (2.62%)
At close: Sep 11, 2026
Medico Intercontinental Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 834.41 | 840.84 | 953.15 | 713.55 | 762.26 | 742.6 |
Other Revenue | 3.95 | 5.25 | 3.22 | 1.52 | 2.96 | 1.2 |
| 838.36 | 846.09 | 956.37 | 715.07 | 765.22 | 743.8 | |
Revenue Growth | -14.97% | -11.53% | 33.75% | -6.55% | 2.88% | 6.61% |
Cost of Revenue | 635.62 | 629.12 | 744.63 | 548.77 | 623.13 | 608.51 |
Gross Profit | 202.75 | 216.97 | 211.74 | 166.3 | 142.09 | 135.29 |
Selling, General & Admin | 103.59 | 97.59 | 62.25 | 64.21 | 43.67 | 44.47 |
Other Operating Expenses | 75.86 | 81.17 | 63.38 | 39.91 | 40.69 | 37.51 |
Operating Expenses | 239.64 | 233.03 | 133.49 | 106.97 | 86.37 | 83.99 |
Operating Income | -36.9 | -16.06 | 78.26 | 59.34 | 55.72 | 51.3 |
Interest Expense | -75.01 | -79.47 | -9.65 | -4.8 | -6.11 | -8.65 |
Earnings From Equity Investments | 1.05 | 1.11 | 1.02 | - | - | - |
Currency Exchange Gain (Loss) | -0.91 | -0.91 | - | - | - | - |
Other Non Operating Income (Expenses) | -1.95 | -1.95 | -0.28 | -0.13 | -0.08 | -0.09 |
EBT Excluding Unusual Items | -113.71 | -97.27 | 69.35 | 54.41 | 49.53 | 42.56 |
Impairment of Goodwill | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.04 |
Gain (Loss) on Sale of Assets | 4.99 | 4.99 | -0.1 | - | - | - |
Pretax Income | -108.73 | -92.3 | 69.23 | 54.39 | 49.5 | 42.53 |
Income Tax Expense | 16.62 | 17.51 | 18.66 | 14.91 | 13.42 | 11.53 |
Earnings From Continuing Operations | -125.35 | -109.8 | 50.57 | 39.47 | 36.08 | 31 |
Minority Interest in Earnings | 85.65 | 77.8 | - | - | - | - |
Net Income | -39.7 | -32.01 | 50.57 | 39.47 | 36.08 | 31 |
Net Income to Common | -39.7 | -32.01 | 50.57 | 39.47 | 36.08 | 31 |
Net Income Growth | - | - | 28.13% | 9.39% | 16.41% | 20.32% |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 6 | 3 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 6 | 3 |
Shares Change | 0.21% | - | - | 55.51% | 97.92% | - |
EPS (Basic) | -3.97 | -3.20 | 5.06 | 3.95 | 5.61 | 9.54 |
EPS (Diluted) | -3.97 | -3.20 | 5.06 | 3.95 | 5.61 | 9.54 |
EPS Growth | - | - | 28.13% | -29.66% | -41.19% | 20.32% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 124.33 | -81.85 | 43.42 | -105.25 | 36.38 |
Free Cash Flow Per Share | - | 12.43 | -8.19 | 4.34 | -16.37 | 11.20 |
Dividend Per Share | - | - | - | - | 0.100 | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 24.18% | 25.64% | 22.14% | 23.26% | 18.57% | 18.19% |
Operating Margin | -4.40% | -1.90% | 8.18% | 8.30% | 7.28% | 6.90% |
Profit Margin | -4.74% | -3.78% | 5.29% | 5.52% | 4.71% | 4.17% |
Free Cash Flow Margin | - | 14.69% | -8.56% | 6.07% | -13.75% | 4.89% |
EBITDA | 28.97 | 38.21 | 86.11 | 62.18 | 57.72 | 53.32 |
EBITDA Margin | 3.45% | 4.52% | 9.00% | 8.70% | 7.54% | 7.17% |
D&A For EBITDA | 65.87 | 54.26 | 7.85 | 2.85 | 2.01 | 2.02 |
EBIT | -36.9 | -16.06 | 78.26 | 59.34 | 55.72 | 51.3 |
EBIT Margin | -4.40% | -1.90% | 8.18% | 8.30% | 7.28% | 6.90% |
Effective Tax Rate | - | - | 26.95% | 27.42% | 27.11% | 27.11% |
Revenue as Reported | 845.82 | 853.55 | 957.32 | 717.57 | 767.38 | 745.66 |
Advertising Expenses | - | 6.06 | 11.92 | 21.33 | 7.7 | 17.74 |